Delcath Systems (STU:DV3R) Current Accrued Expense : €2.60 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Delcath Systems Current Accrued Expense?

Delcath Systems's Current Accrued Expense for the quarter that ended in Mar. 2024 was €2.60 Mil.

Delcath Systems's quarterly Current Accrued Expense declined from Sep. 2023 (€3.46 Mil) to Dec. 2023 (€3.11 Mil) and declined from Dec. 2023 (€3.11 Mil) to Mar. 2024 (€2.60 Mil).

Delcath Systems's annual Current Accrued Expense increased from Dec. 2021 (€1.50 Mil) to Dec. 2022 (€3.44 Mil) but then declined from Dec. 2022 (€3.44 Mil) to Dec. 2023 (€3.11 Mil).

Delcath Systems Current Accrued Expense Historical Data

The historical data trend for Delcath Systems's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Current Accrued Expense Chart

Delcath Systems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

0.83

0.78

1.50

3.44

3.11

Delcath Systems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															2.95	3.89	3.46	3.11	2.60

Delcath Systems Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Delcath Systems Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Delcath Systems's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems (STU:DV3R) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (STU:DV3R) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

DCTH:USA DV3R:Germany

Address

1633 Broadway, Suite 22C, New York, NY, USA, 10019

Website

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Delcath Systems (STU:DV3R) Headlines

No Headlines